NasdaqGM - Nasdaq Real Time Price USD
Castle Biosciences, Inc. (CSTL)
16.32
-0.71
(-4.17%)
At close: May 14 at 4:00:00 PM EDT
16.99
+0.67
+(4.11%)
Pre-Market: 8:18:39 AM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 201,075 | 9 |
Sales | 143,464 | 16 |
Net Shares Purchased (Sold) | 57,611 | 25 |
Total Insider Shares Held | 798.9k | -- |
% Net Shares Purchased (Sold) | 7.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
MAETZOLD DEREK J Chief Executive Officer | Sale at price 21.52 per share. | Indirect | 121,448 | Apr 21, 2025 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 20.03 - 20.22 per share. | Indirect | 113,932 | Apr 9, 2025 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 20.30 per share. | Indirect | 114,573 | Mar 26, 2025 |
COTTON RODNEY Director | -- | Direct | -- | Mar 26, 2025 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 19.52 - 20.74 per share. | Indirect | 585,673 | Mar 10, 2025 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 20.86 per share. | Indirect | 118,619 | Mar 4, 2025 |
JUVENAL TOBIN W Officer | -- | Direct | -- | Mar 4, 2025 |
MAETZOLD DEREK J Chief Executive Officer | -- | Direct | -- | Mar 4, 2025 |
STOKES FRANK Chief Financial Officer | -- | Direct | -- | Mar 4, 2025 |
OELSCHLAGER KRISTEN M Chief Operating Officer | -- | Direct | -- | Mar 4, 2025 |
STOKES FRANK Chief Financial Officer | Sale at price 26.70 per share. | Direct | 214,828 | Feb 20, 2025 |
BRADBURY DANIEL M Director | Sale at price 28.17 per share. | Indirect | 221,637 | Feb 5, 2025 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 27.51 - 29.48 per share. | Indirect | 71,903 | Jan 13, 2025 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 28.42 - 30.18 per share. | Indirect | 228,067 | Jan 7, 2025 |
BRADBURY DANIEL M Director | Sale at price 28.39 - 29.82 per share. | Indirect | 229,226 | Jan 6, 2025 |
JUVENAL TOBIN W Officer | Sale at price 30.00 per share. | Direct | 66,900 | Jan 6, 2025 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 28.33 - 28.76 per share. | Direct | 265,358 | Dec 17, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 28.47 - 29.16 per share. | Indirect | 750,296 | Dec 16, 2024 |
MAETZOLD DEREK J Chief Executive Officer | -- | Direct | -- | Dec 10, 2024 |
STOKES FRANK Chief Financial Officer | -- | Direct | -- | Dec 10, 2024 |
OELSCHLAGER KRISTEN M Chief Operating Officer | -- | Direct | -- | Dec 10, 2024 |
JUVENAL TOBIN W Officer | -- | Direct | -- | Dec 10, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 31.35 per share. | Indirect | 160,742 | Dec 5, 2024 |
BRADBURY DANIEL M Director | Sale at price 30.95 - 31.32 per share. | Indirect | 243,693 | Dec 3, 2024 |
STOKES FRANK Chief Financial Officer | Sale at price 29.87 - 30.40 per share. | Direct | 207,217 | Nov 15, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 34.15 per share. | Indirect | 175,087 | Nov 12, 2024 |
JUVENAL TOBIN W Officer | Sale at price 35.56 per share. | Direct | 124,709 | Nov 5, 2024 |
JUVENAL TOBIN W Officer | Conversion of Exercise of derivative security at price 3.38 per share. | Direct | 11,854 | Nov 5, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 32.53 - 33.16 per share. | Indirect | 166,820 | Nov 4, 2024 |
BRADBURY DANIEL M Director | Sale at price 33.90 - 35.33 per share. | Indirect | 273,251 | Nov 1, 2024 |
JUVENAL TOBIN W Officer | Sale at price 35.39 per share. | Direct | 109,709 | Nov 1, 2024 |
JUVENAL TOBIN W Officer | Conversion of Exercise of derivative security at price 3.38 per share. | Direct | 3,718 | Nov 1, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 32.27 per share. | Indirect | 165,464 | Oct 14, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 30.27 per share. | Indirect | 77,549 | Oct 8, 2024 |
BRADBURY DANIEL M Director | Sale at price 29.44 per share. | Indirect | 231,628 | Oct 7, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 28.73 per share. | Indirect | 73,703 | Oct 4, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 30.97 per share. | Indirect | 158,793 | Sep 16, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 30.32 per share. | Indirect | 79,317 | Sep 11, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 29.46 per share. | Indirect | 76,176 | Sep 9, 2024 |
BRADBURY DANIEL M Director | Sale at price 29.02 per share. | Indirect | 228,332 | Sep 5, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 30.02 - 30.05 per share. | Indirect | 57,493 | Sep 4, 2024 |
OELSCHLAGER KRISTEN M Chief Operating Officer | Sale at price 29.00 - 29.97 per share. | Direct | 170,330 | Sep 3, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 30.08 - 30.10 per share. | Indirect | 133,584 | Aug 30, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Sale at price 30.05 - 30.09 per share. | Indirect | 89,868 | Aug 26, 2024 |
BRADBURY DANIEL M Director | Sale at price 26.65 per share. | Indirect | 210,058 | Aug 12, 2024 |
MAETZOLD DEREK J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
STOKES FRANK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
OELSCHLAGER KRISTEN M Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
JUVENAL TOBIN W Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
STOKES FRANK Chief Financial Officer | Sale at price 25.20 - 26.13 per share. | Direct | 256,997 | Aug 7, 2024 |
Related Tickers
VCYT Veracyte, Inc.
28.49
-2.80%
PSNL Personalis, Inc.
4.8200
-6.23%
CDNA CareDx, Inc
16.02
-0.68%
FLGT Fulgent Genetics, Inc.
19.66
-3.10%
WGSWW GeneDx Holdings Corp.
0.0499
-1.19%
TWST Twist Bioscience Corporation
29.52
-8.58%
GH Guardant Health, Inc.
40.72
-1.55%
RVTY Revvity, Inc.
91.02
-5.88%
WGS GeneDx Holdings Corp.
59.45
-2.43%
EXAS Exact Sciences Corporation
54.87
+2.24%